Clinical Trials Directory

Trials / Suspended

SuspendedNCT04189991

Oxygen Titration Protocol for Exertion of COPD Patients by an Automated Adjustment Device

Oxygen Titration Protocol for Exertion of COPD Patients by an Automated Adjustment Device: a Monocentric, Prospective, Cross-over Study.

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
ADIR Association · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to assess if an automated titration of oxygen flow during exertion can be a useful tool to determinate the level of oxygen required by COPD patients that are using oxygen therapy during exercise.

Detailed description

All patients referred to our centre of oxygen titration during exertion will be offered to participate in our study. After baseline assessments, patients will have an oxygen titration using two different methods in random order: * Usual titration protocol will include an manual oxygen increase during a titration 6 minutes walk test * Automatic titration protocol that will use the automated oxygen titration device to adjust oxygen flow rate during a titration 6 minutes walk test. After each titration protocol, the efficacy of the titration will be assessed in 3 validation 6 minutes walk tests during which oxygen flow will be set at: * The manually determined flow rate * The 95th percentile flow rate of the automatic titration * The median flow rate of the automatic titration During validation 6 minutes walk test, oxygen saturation, dyspnea, walked distance and heart rate will be recorded.

Conditions

Interventions

TypeNameDescription
DEVICEFree 02With the manual oxygen titration, the physiotherapist adjust manually the oxygen flow using the FreeO2 device during a titration 6 minutes walk test. With the automated adjustment oxygen titration, the flow will be self adjusted by the FreeO2 device during a titration 6 minutes walk test. In that hase, the median flow rate and the 95th flow rate will be evaluated during the validation 6 minutes walk test.

Timeline

Start date
2020-02-06
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2019-12-09
Last updated
2023-11-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04189991. Inclusion in this directory is not an endorsement.